Finance & Investment (Pharma & Healthcare)


Finance and Investment (Pharma and Healthcare) Market Research Reports Analysis and Trends

The Finance and Investment in Pharma and Healthcare industry gives information on budgets, supplier selection criteria, business challenges and investment opportunities of leading purchase decision makers. The report also gives information on future growth of buyers and suppliers, e-procurement, opinions and strategies of business decision makers and competitors, business priorities, company type and sizes respectively, market analysis of the pharmaceutical company.

The Key features of Finance and Investment in Pharma and Healthcare industry reports are:  

  • Profits growth and future developments in business structure of pharmaceutical industry.
  • Merger and acquisition activity of Pharma companies.
  • Capital expenditure and change in staff recruitment activity in Pharma companies.
  • Key regions of growth within the company.
  • Key industry threats and opportunities of pharmaceutical industry.
  • Key supplier actions and e-procurement.
  • Annual procurement budgets and change in procurement expenditure.
  • Change in supplier selection and procurement objectives of the company.
  • Costs involved in various pharmaceutical company products.
Title Published Pages Price
Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2019 Apr 1 2019 357 USD 2,995.00
Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2019 Apr 1 2019 262 USD 2,995.00
Global Gastrointestinal Partnering 2014-2019: Deal trends, players and financials Apr 1 2019 250 USD 3,495.00
Global Central Nervous System Partnering 2014-2019: Deal trends, players and financials Apr 1 2019 700 USD 3,495.00
Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 Apr 1 2019 619 USD 2,995.00
Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 Apr 1 2019 794 USD 2,995.00
Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2019 Apr 1 2019 881 USD 2,995.00
Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2019 Apr 1 2019 4000 USD 2,995.00
Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 Apr 1 2019 252 USD 2,995.00
Global Dermatology Partnering 2014-2019: Deal trends, players and financials Apr 1 2019 300 USD 3,495.00
Global Cardiovascular Partnering 2014-2019: Deal trends, players and financials Apr 1 2019 400 USD 3,495.00
Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2019 Apr 1 2019 530 USD 2,995.00
Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2019 Apr 1 2019 1700 USD 2,995.00
Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2014-2019 Apr 1 2019 151 USD 2,995.00
Emerging Gene Therapies - Trends within the Technological, Clinical, Regulatory and Competitive Landscape Jan 3 2019 99 USD 2,995.00
Global Biosimilars Market - Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling Biologics Jan 1 2019 108 USD 2,995.00
Global Clinical Trials - Current Trends and Recent Advancement Jan 1 2019 65 USD 2,995.00
Innovation Tracking Factbook 2018: An Assessment of the Pharmaceutical Pipeline Dec 14 2018 57 USD 2,995.00
Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 Nov 1 2018 1000 USD 2,995.00
Global Stem Cell Partnering 2010-2018: Deal trends, players and financials Nov 1 2018 370 USD 2,995.00
Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012 to 2018 Nov 1 2018 1200 USD 2,995.00
Global Biomarker Partnering Terms and Agreements 2010-2018: Deal trends, players and financials Nov 1 2018 658 USD 2,995.00
Global Pharmaceutical Partnering Terms and Agreements 2012-2018: Deal trends, players and financials Nov 1 2018 1000 USD 2,995.00
Global Antibiotics Partnering Terms and Agreements 2010 to 2018: Deal trends, players and financials Nov 1 2018 222 USD 2,995.00
Global Drug Delivery Partnering 2010-2018: Deal trends, players and financials Nov 1 2018 1000 USD 3,495.00
Global Infectious Vaccines Partnering Terms and Agreements 2010 to 2018: Deal trends, players and financials Nov 1 2018 450 USD 2,995.00
Global Cancer Diagnostics Partnering 2010-2018: Deal trends, players and financials Nov 1 2018 700 USD 2,995.00
Global Vaccine Partnering Terms and Agreements 2010-2018: Deal trends, players and financials Nov 1 2018 700 USD 2,995.00
Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012 to 2018 Nov 1 2018 750 USD 2,995.00
Global In Vitro Diagnostics Partnering 2010-2018: Deal trends, players and financials Nov 1 2018 660 USD 2,995.00
Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2012-2018 Nov 1 2018 2500 USD 2,995.00
Global Precision Medicine Partnering 2010-2018: Deal trends, players and financials Nov 1 2018 1000 USD 3,495.00
Global Biotech Partnering Terms and Agreements 2012-2018: Deal trends, players and financials Nov 1 2018 1000 USD 2,995.00
Global Companion Diagnostics Partnering 2010-2018: Deal trends, players and financials Nov 1 2018 248 USD 2,995.00
Global Artificial Intellgence (AI) LPartnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010 to 2018 Nov 1 2018 140 USD 1,995.00
Global Antibody Partnering Terms and Agreements 2010-2018: Deal trends, players and financials Nov 1 2018 850 USD 2,995.00
Global Diagnostics Partnering 2010-2018: Deal trends, players and financials Nov 1 2018 1000 USD 3,495.00
Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010-2018: Deal trends, players and financials Nov 1 2018 300 USD 2,995.00
Global Cancer Vaccine Partnering 2010-2018: Deal trends, players and financials Nov 1 2018 200 USD 2,995.00
Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 Nov 1 2018 800 USD 2,995.00
Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players Oct 12 2018 93 USD 2,995.00
Global Orphan Diseases Partnering 2012-2018: Deal trends, players and financials Oct 1 2018 250 USD 2,995.00
Global Big Pharma Partnering Terms and Agreements 2012-2018: Deal trends, players and financials Oct 1 2018 1000 USD 2,995.00
Global Respiratory Syncytial Virus Partnering 2012-2018 Oct 1 2018 150 USD 1,995.00
Global Congestive Heart Failure Partnering 2012 to 2018 Oct 1 2018 100 USD 1,995.00
Global Asthma Partnering 2012 to 2018 Oct 1 2018 100 USD 1,995.00
Global Cystic Fibrosis Partnering 2012 to 2018 Oct 1 2018 100 USD 1,995.00
Global Allergy Partnering 2012 to 2018 Oct 1 2018 150 USD 1,995.00
Global Leukemia Partnering 2012 to 2018 Oct 1 2018 150 USD 1,995.00
Global Monoclonal Antibody Partnering Terms and Agreements 2012-2018: Deal trends, players and financials Oct 1 2018 500 USD 2,995.00

Clients Who Trust Us

Need tailor made market research solution? We can help you with that too.

About Us

At Market Research Reports, Inc. we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer’s needs, be it custom research or syndicated research reports.

Contact Us

Market Research Reports, Inc
16192 Coastal Hwy
Lewes
, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

User login